scholarly journals IDENTIFYING POST-PARTUM OPTIC NEURITIS IN RURAL AREAS: A CASE REPORT

2020 ◽  
Vol 3 (3) ◽  
pp. 96-99
Author(s):  
Harris Kristanto Soedjono ◽  
Candida Isabel Lopes Sam
Keyword(s):  
Visual Acuity ◽  
Autoimmune Disease ◽  
Optic Neuritis ◽  
Rural Areas ◽  
Vision Loss ◽  
Post Partum ◽  
High Dose ◽  
Folic Acid Deficiency ◽  
Demyelinating Process ◽  
Post Partum Period

Background: Optic neuritis is an inflammatory demyelinating process that causes acute impairment of vision that may appear in one or both eyes, either simultaneously or successively. Case: A 22-year-old woman admitted to Neurology Clinic with chief complaint of sudden vision loss in both eyes simultaneously in the last two days. Additional complaints like headache and dizziness also occur. The patient was in her 7th day of post-partum period when this happened. There was no problem during pregnancy nor delivery. The initial visual acuity was 1/300 in both eyes. The patient then admitted and treated with high-dose corticosteroid. After treatment, the patient went home with visual acuity of more than 6/60. Discussion: This patient may have B6, B12, and folic acid deficiency that can cause demyelinating process of optic nerve. It is also possible as an early manifestation of Multiple Sklerosis, an autoimmune process that arises during post-partum period. Conclusion: Pregnancy has a protective effect to autoimmune disease, whereas post-partum period is immunologically more vulnerable to autoimmune disease. Keywords: optic neuritis, post-partum, sudden vision loss

scholarly journals MOG-related bilateral optic neuritis in a patient with cystic fibrosis

2021 ◽  
Vol 2 (3) ◽  
Author(s):  
Rachelle Abi Nahed ◽  
◽  
Georges Succarieh ◽  
Amine Al Soueidy ◽  
Patrick Baz ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Visual Acuity ◽  
Optic Neuritis ◽  
Optic Neuropathy ◽  
Complete Resolution ◽  
Myelin Oligodendrocyte Glycoprotein ◽  
Acute Onset ◽  
Optic Disk ◽  
High Dose

Optic neuropathy secondary to Cystic Fibrosis (CF) has been described as a manifestation of chloramphenicol toxicity. Inflammatory optic neuritis and Myelin Oligodendrocyte Glycoprotein (MOG)-related disorders have not been previously described in patients with CF. We report the case of a 19-year-old woman with cystic fibrosis who presented for sub-acute onset decreased visual acuity, dyschromatopsia, and optic disk swelling in both eyes, with near-complete resolution after a course of high-dose corticosteroids. MOG-IgG were positive in the serum. MOG-related optic neuritis can occur in CF and represent a diagnostic and long-term therapeutic challenge. Keywords: Optic neuritis; MOG; cystic fibrosis.

scholarly journals Infliximab-related Optic Neuritis in a Patient with Crohn's Disease: a Case Report and Literature Review

2021 ◽  
Vol 62 (8) ◽  
pp. 1160-1166
Author(s):  
Su Hwan Park ◽  
Min Seung Kang ◽  
Sang Yoon Kim ◽  
Ji-Eun Lee ◽  
Su Jin Kim
Keyword(s):  
Visual Acuity ◽  
Crohn’S Disease ◽  
Visual Field ◽  
Crohn's Disease ◽  
Optic Neuritis ◽  
Visual Field Defect ◽  
High Dose ◽  
Infliximab Treatment ◽  
Blurred Vision ◽  
Field Defect

Purpose: We report a case of optic neuritis related to infliximab treatment in a patient with Crohn’s disease, along with a review of the relevant literature.Case summary: A 22-year-male patient complained of blurred vision in the left eye for 2-3 weeks. His best-corrected visual acuity was 8/20 in the left eye. Relative afferent pupillary defect was detected in the left eye and the pupils were of equal size. There was no pain on ocular movement. The results of slit-lamp and fundus examinations were normal. A visual field test revealed a central to inferior visual field defect in the left eye. Orbit magnetic resonance imaging revealed perineural enhancement of the left optic nerve. He had a 5-year history of Crohn’s disease and had been treated with intravenous infliximab (600 mg every 2 weeks). A diagnosis of retrobulbar optic neuritis associated with infliximab was made. He was infused with high-dose methylprednisolone, which was changed to per oral administration. His visual acuity and visual field defect improved after 3 months.Conclusions: Tumor necrosis factor-α inhibitors, such as infliximab, may cause optic neuritis. Therefore, history-taking is important for differential diagnosis and appropriate treatment.

scholarly journals Optic neuritis as the ocular manifestation of dengue infection: a case report

2021 ◽  
Vol 3 (1) ◽  
pp. 46-51
Author(s):  
Indra Tri Mahayana ◽  
Andreas Surya Anugrah ◽  
Ika Kartika ◽  
Natalia Christina Angsana ◽  
Tatang Talka Gani
Keyword(s):  
Visual Acuity ◽  
Optic Neuritis ◽  
Vision Loss ◽  
Early Recognition ◽  
Dengue Infection ◽  
Young Female ◽  
Blurred Vision ◽  
Colour Perception ◽  
Optic Neuritis Treatment Trial ◽  
Optic Discs

Optic neuritis is characterized by decreased vision, impaired colour perception, relative afferent pupillary defects, and scotoma. Optic neuritis following dengue infection is rare and might be underdiagnosed. The pathophysiology of optic neuritis after dengue infection is still unclear and there are only a few reports. We report a case of bilateral simultaneous optic neuritis in a young female adult following dengue haemorrhagic fever. On presentation, she complained of blurred vision, pain around the eyes, central scotoma, and progressively worsening visual acuity to no perception of light in both eyes. The next day, laboratory examination showed leucopoenia (6.74 [4.5–11.5 103/μL]) and lymphocytosis (52.7 [18–42%]), suggesting viral infection with positive anti-dengue IgM and IgG. The patient received intravenous pulse steroid therapy according to the Optic Neuritis Treatment Trial. At 3 months follow-up, best corrected visual acuity improved to 6/6, with pale optic discs but normal perimetry. Although complications of dengue fever in the eye are rare, early recognition must be established to prevent permanent vision loss.

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Canada

2020 ◽  
pp. 1-6
Author(s):  
Anubhav Garg ◽  
Edward Margolin ◽  
Jonathan A. Micieli
Keyword(s):  
Optic Neuritis ◽  
Clinical Characteristics ◽  
Vision Loss ◽  
Brain Mri ◽  
Visual Fields ◽  
Case Series ◽  
Myelin Oligodendrocyte Glycoprotein ◽  
Mean Deviation ◽  
High Dose ◽  
Rnfl Thickness

ABSTRACT: Objective: To describe clinical characteristics of Canadian patients with myelin-oligodendrocyte glycoprotein immunoglobulin-G optic neuritis (MOG-IgG ON). Methods: Retrospective observational case series of MOG-IgG seropositive patients with ON referred to tertiary neuro-ophthalmology practices. Outcome measures included clinical characteristics, radiologic findings, and visual outcomes. Results: Forty-six eyes of 30 patients were included. Twenty-three (76.7%) were women, mean onset age was 40.7 years (range 16–77), and most were Caucasian. Seventeen (56.7%) presented with their first ON episode. Sixteen (53.3%) had bilateral eye involvement. Isolated ON without associated neurological symptoms occurred in 90.0%. In 22 patients with acute ON (seen within 1 month of onset), presenting mean visual acuity (VA) was 20/258 (logMAR 1.11), mean deviation (MD) on Humphrey visual fields was −16.90 ± 10.83 dB, and peripapillary retinal nerve fiber layer (RNFL) thickness on ocular coherence tomography (OCT) was 164.23 ± 46.53 um. Orbital magnetic resonance imaging (MRI) within 1 month of symptom onset for 19 patients demonstrated orbital optic nerve enhancement in 11 (57.9%) and perineural enhancement in 11 (57.9%). Brain MRI was normal in 28 (93.3%) patients. Twenty out of 22 patients with acute presentation were treated with high-dose glucocorticoids and 5 with plasma exchange in addition to corticosteroids. Long-term immunosuppression was utilized in 9 (30%) out of all 30 patients. Final VA was 20/30 (logMAR 0.18), MD was −7.17 ± 8.85 dB, and RNFL thickness was 72.15 ± 20.16 um. Conclusion: MOG-IgG ON in Canada has a variable presentation with most patients having substantial initial vision loss with good recovery. This is the largest characterization of the disease in Canada to date.

High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss

2020 ◽  
pp. 39-44
Author(s):  
Alan D. Penman ◽  
Kimberly W. Crowder ◽  
William M. Watkins
Keyword(s):  
Visual Acuity ◽  
Vision Loss ◽  
Beta Carotene ◽  
High Dose ◽  
Age Related ◽  
History Of ◽  
Visual Acuity Loss ◽  
Lens Opacities ◽  
Antioxidant Characteristics ◽  
Disease Study

The Age-Related Eye Disease Study (AREDS) was a multicenter study of the natural history of age-related cataract and macular degeneration (AMD) in a relatively well-nourished older adult cohort that comprised two clinical trials sharing one pool of participants. The study was designed to determine whether a high-dose antioxidant formulation affected the development and progression of age-related lens opacities and visual acuity loss. The cataract trial showed that use of a high-dose formulation of vitamins having antioxidant characteristics (vitamin C, vitamin E, and beta carotene) had no apparent effect on the 7-year risk of development or progression of age-related lens opacities or visual acuity loss.

104 Severe unilateral optic neuritis in multiple sclerosis

2018 ◽  
Vol 89 (6) ◽  
pp. A41.2-A41
Author(s):  
Natasha Gerbis ◽  
John Parratt
Keyword(s):  
Multiple Sclerosis ◽  
Visual Acuity ◽  
Optic Neuritis ◽  
Visual Loss ◽  
Case Series ◽  
Retinal Nerve Fibre Layer ◽  
High Dose ◽  
List Type ◽  
The Mean

IntroductionOptic neuritis (ON) results in acute loss of vision with pain on eye movement. It may be the first manifestation of multiple sclerosis (MS) and usually follows a resolving course. Here we describe five patients with MS who developed severe unilateral ON resulting in persistent visual loss without significant resolution.MethodsA retrospective clinical review of five cases identified from a database of 550 patients with MS.ResultsAll patients were female and the mean age was 30 years at onset (range 25–40). All patients had no light perception at diagnosis, and received treatment with high dose intravenous methylprednisolone. Two patients also had plasma exchange. All of the patients were subsequently treated with immunomodulatory therapy. The patients were followed for a mean period of 13.3 years (range 2 months to 31 years). None of the patients had significant improvement in their visual acuity, with most achieving vision of 6/60. The mean retinal nerve fibre layer thickness was 66.33 microns (range 46–98 microns) in the affected eye, compared to 86.7 microns (69–105 microns) in the unaffected eye. All patients were aquaporin-4 antibody negative and oligoclonal band positive, with the MRI brain and spine being diagnostic for MS. Interestingly, none of the patients developed significant symptoms in the contralateral eye with vision of 6/5. All patients had an EDSS score of 4.0 predominantly due to visual impairment.ConclusionSevere unilateral ON is rarely seen in MS. This case series highlights a phenotypically distinct group of female MS patients with severe unilateral ON, and no improvement in visual acuity after prolonged follow-up and despite treatment with steroids and potent immune therapies. In such patients, where the diagnosis of MS is confirmed by MRI and CSF analysis, the patient might be reassured that visual loss in the fellow eye is unlikely.References. Wilhelm H, Schabet M. The diagnosis and treatment of optic neuritis. Deutsches Arzteblatt International2015;112(37):616–626.. Dachsel RM, et al. Optic neuropathy after retrobulbar neuritis in multiple sclerosis: Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?Der Nervenarzt2015;86(2):187–96.

Low back pain in pregnancy and post-partum period. Principles for medical rehabilitation

2018 ◽  
Vol 1 (19) ◽  
pp. 22
Author(s):  
Iulia Filipescu ◽  
Mihai Berteanu ◽  
George Alexandru Filipescu ◽  
Radu Vlădăreanu
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Post Partum ◽  
Medical Rehabilitation ◽  
Low Back ◽  
Post Partum Period ◽  
In Pregnancy

Management of Optic Neuritis in Ayurveda - A Special Case Report

2018 ◽  
Vol 3 (5) ◽  
Author(s):  
Dr. Harsha S. ◽  
Dr. Mamatha KV.
Keyword(s):  
Optic Nerve ◽  
Optic Neuritis ◽  
Visual Information ◽  
Vision Loss ◽  
Specific Treatment ◽  
Interesting Case ◽  
Treatment Modalities ◽  
Further Development ◽  
Special Case

The optic nerve carries visual information from your eye to your brain. Optic neuritis is when your optic nerve becomes inflamed. Optic neuritis can flare up suddenly from an infection or nerve disease. The inflammation usually causes temporary vision loss that typically happens in only one eye. Those with Optic neuritis sometimes experience pain. As you recover and the inflammation goes away, your vision will likely return. There are no direct references in our classics regarding optic neuritis but can be contemplated as a condition by name Parimlayi Timira. The specific management as such is not cited but a transcendence approach can be done with adopting the treatment which has the ability to pacify the already occurred pathology and prevent the further development of the disease. One such interesting case study on Optic neuritis is elaborated here where in specific treatment modalities (Shodana, Shamana and Kriyakalpas) played role in pacifying the condition.

scholarly journals Using Anti-Cancer Agents during the Post-Partum Period: Not that Simple

Onkologie ◽  
2010 ◽  
Vol 33 (8-9) ◽  
pp. 419-419 ◽  
Author(s):  
Olivier Mir ◽  
Paul Berveiller ◽  
Raphaël Serreau
Keyword(s):  
Post Partum ◽  
Anti Cancer ◽  
Post Partum Period
Sign in / Sign up

Export Citation Format

Share Document